Sichuan Hebang Biotechnology Performance dei guadagni passati
Il passato criteri di controllo 2/6
Sichuan Hebang Biotechnology has been growing earnings at an average annual rate of 18.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 12.7% per year. Sichuan Hebang Biotechnology's return on equity is 2.4%, and it has net margins of 5.3%.
Informazioni chiave
18.7%
Tasso di crescita degli utili
18.4%
Tasso di crescita dell'EPS
| Chemicals Crescita del settore | 12.1% |
| Tasso di crescita dei ricavi | 12.7% |
| Rendimento del capitale proprio | 2.4% |
| Margine netto | 5.3% |
| Ultimo aggiornamento sui guadagni | 30 Sep 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Returns On Capital At Sichuan Hebang Biotechnology (SHSE:603077) Have Stalled
Sep 25
Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Shares Not Telling The Full Story
Aug 16Return Trends At Sichuan Hebang Biotechnology (SHSE:603077) Aren't Appealing
Jun 04Investors Holding Back On Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077)
May 13Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?
Mar 07Here's Why I Think Sichuan Hebang Biotechnology (SHSE:603077) Is An Interesting Stock
Apr 21Ripartizione dei ricavi e delle spese
Come Sichuan Hebang Biotechnology guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Sep 24 | 9,203 | 486 | 499 | 41 |
| 30 Jun 24 | 9,582 | 859 | 499 | 44 |
| 31 Mar 24 | 8,429 | 916 | 479 | 47 |
| 31 Dec 23 | 8,824 | 1,283 | 471 | 47 |
| 30 Sep 23 | 8,980 | 1,398 | 534 | 72 |
| 30 Jun 23 | 9,651 | 1,789 | 669 | 69 |
| 31 Mar 23 | 12,347 | 3,161 | 796 | 69 |
| 31 Dec 22 | 13,039 | 3,807 | 883 | 68 |
| 30 Sep 22 | 13,353 | 4,438 | 701 | 34 |
| 30 Jun 22 | 13,517 | 4,741 | 612 | 34 |
| 31 Mar 22 | 11,409 | 3,815 | 454 | 33 |
| 31 Dec 21 | 9,987 | 3,018 | 341 | 33 |
| 30 Sep 21 | 8,494 | 2,248 | 234 | 33 |
| 30 Jun 21 | 6,768 | 908 | 203 | 36 |
| 31 Mar 21 | 5,902 | 319 | 267 | 37 |
| 31 Dec 20 | 5,261 | 41 | 310 | 40 |
| 30 Sep 20 | 5,115 | -147 | 457 | 41 |
| 30 Jun 20 | 5,351 | 264 | 520 | 40 |
| 31 Mar 20 | 5,565 | 372 | 510 | 40 |
| 31 Dec 19 | 5,969 | 517 | 498 | 38 |
| 30 Sep 19 | 6,200 | 380 | 586 | 38 |
| 30 Jun 19 | 6,154 | 387 | 563 | 34 |
| 31 Mar 19 | 6,285 | 426 | 570 | 33 |
| 31 Dec 18 | 6,009 | 363 | 548 | 31 |
| 30 Sep 18 | 5,990 | 622 | 517 | 37 |
| 30 Jun 18 | 5,625 | 535 | 453 | 50 |
| 31 Mar 18 | 4,961 | 395 | 458 | 42 |
| 31 Dec 17 | 4,738 | 518 | 459 | 35 |
| 30 Sep 17 | 4,400 | 477 | 438 | 19 |
| 30 Jun 17 | 4,041 | 451 | 436 | 0 |
| 31 Mar 17 | 3,722 | 436 | 419 | 0 |
| 31 Dec 16 | 3,463 | 318 | 396 | 0 |
| 30 Sep 16 | 3,206 | 260 | 351 | 0 |
| 30 Jun 16 | 2,954 | 226 | 328 | 0 |
| 31 Mar 16 | 3,043 | 255 | 301 | 0 |
| 31 Dec 15 | 2,863 | 240 | 246 | 0 |
| 30 Sep 15 | 2,757 | 144 | 239 | 0 |
| 30 Jun 15 | 2,628 | 135 | 206 | 0 |
| 31 Mar 15 | 2,282 | 679 | 173 | 0 |
| 31 Dec 14 | 2,186 | 672 | 179 | 0 |
| 30 Sep 14 | 1,979 | 715 | 190 | 0 |
| 30 Jun 14 | 1,871 | 696 | 166 | 0 |
| 31 Mar 14 | 1,660 | 54 | 160 | 0 |
| 31 Dec 13 | 1,603 | 64 | 150 | 0 |
Guadagni di qualità: 603077 has high quality earnings.
Margine di profitto in crescita: 603077's current net profit margins (5.3%) are lower than last year (15.6%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: 603077's earnings have grown by 18.7% per year over the past 5 years.
Accelerare la crescita: 603077's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Guadagni vs Settore: 603077 had negative earnings growth (-65.3%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendimento del capitale proprio
ROE elevato: 603077's Return on Equity (2.4%) is considered low.